LEONARD JOHN M 4
4 · Intellia Therapeutics, Inc. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
LEONARD JOHN M
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2024-01-01+7,848→ 865,709 total - Exercise/Conversion
Restricted Stock Unit
2024-01-01−7,848→ 7,850 totalFrom: 2024-01-01Exp: 2031-03-02→ Common Stock (7,848 underlying)
Holdings
- 58,415(indirect: By Trust)
Common Stock
Footnotes (3)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]Shares held by the John M. Leonard 2015 Irrevocable Trust.
- [F3]On March 3, 2021, the reporting person was granted 31,394 RSUs pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan. Each RSU represents a contingent right to receive one share of the Company's common stock upon vesting, with 25% of the RSU vesting on January 1, 2022 and the remaining awards vesting as to 25% in substantially equal annual installments thereafter.